Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 50027935
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256669((2S,3R)-2-(3-(3-mesitylureido)-2-naphthamido)-3-(1...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27726((2S,3R)-3-(tert-butoxy)-2-[(3-{[(2,4,6-trimethylph...)
Affinity DataIC50: 7nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256573((S)-2-(3-(3-mesitylureido)-2-naphthamido)-5-methyl...)
Affinity DataIC50: 9nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256710((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 16nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256668((2S,3R)-3-cyclobutoxy-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 17nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256667((2S,3R)-3-isopropoxy-2-(3-(3-mesitylureido)-2-naph...)
Affinity DataIC50: 17nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256521((S)-2-(3-(3-mesitylureido)-2-naphthamido)hexanoic ...)
Affinity DataIC50: 23nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256711((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 24nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256574((S)-2-(3-(3-mesitylureido)-2-naphthamido)-5,5-dime...)
Affinity DataIC50: 25nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256443((S)-2-(3-(3-mesitylureido)-2-naphthamido)pentanoic...)
Affinity DataIC50: 39nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256620((S)-3-tert-butoxy-2-(3-(3-mesitylureido)-2-naphtha...)
Affinity DataIC50: 44nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256712((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 50nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256575((S)-3-ethoxy-2-(3-(3-mesitylureido)-2-naphthamido)...)
Affinity DataIC50: 56nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256444((2S,3S)-2-(3-(3-mesitylureido)-2-naphthamido)-3-me...)
Affinity DataIC50: 72nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256712((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 73nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256621((S)-2-(3-(3-mesitylureido)-2-naphthamido)-3-(neope...)
Affinity DataIC50: 79nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256622((S)-3-butoxy-2-(3-(3-mesitylureido)-2-naphthamido)...)
Affinity DataIC50: 95nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256520((S)-2-(3-(3-mesitylureido)-2-naphthamido)-4-methyl...)
Affinity DataIC50: 101nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256523(2-(3-(3-mesitylureido)-2-naphthamido)heptanoic aci...)
Affinity DataIC50: 114nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256522(6,6,6-trifluoro-2-(3-(3-mesitylureido)-2-naphthami...)
Affinity DataIC50: 123nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27726((2S,3R)-3-(tert-butoxy)-2-[(3-{[(2,4,6-trimethylph...)
Affinity DataIC50: 139nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256576((S)-3-isopropoxy-2-(3-(3-mesitylureido)-2-naphtham...)
Affinity DataIC50: 148nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256667((2S,3R)-3-isopropoxy-2-(3-(3-mesitylureido)-2-naph...)
Affinity DataIC50: 156nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256669((2S,3R)-2-(3-(3-mesitylureido)-2-naphthamido)-3-(1...)
Affinity DataIC50: 159nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256623((2S,3R)-2-(3-(3-mesitylureido)-2-naphthamido)-3-me...)
Affinity DataIC50: 298nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256711((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 309nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256442((S)-2-(3-(3-mesitylureido)-2-naphthamido)-3,3-dime...)
Affinity DataIC50: 311nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256574((S)-2-(3-(3-mesitylureido)-2-naphthamido)-5,5-dime...)
Affinity DataIC50: 311nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256441((S)-2-(3-(3-mesitylureido)-2-naphthamido)-3-methyl...)
Affinity DataIC50: 387nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence plate reader assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256620((S)-3-tert-butoxy-2-(3-(3-mesitylureido)-2-naphtha...)
Affinity DataIC50: 387nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256710((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 420nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256668((2S,3R)-3-cyclobutoxy-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 434nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256574((S)-2-(3-(3-mesitylureido)-2-naphthamido)-5,5-dime...)
Affinity DataIC50: 450nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256576((S)-3-isopropoxy-2-(3-(3-mesitylureido)-2-naphtham...)
Affinity DataIC50: 451nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256573((S)-2-(3-(3-mesitylureido)-2-naphthamido)-5-methyl...)
Affinity DataIC50: 452nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256521((S)-2-(3-(3-mesitylureido)-2-naphthamido)hexanoic ...)
Affinity DataIC50: 501nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256712((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 613nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256711((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 680nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256444((2S,3S)-2-(3-(3-mesitylureido)-2-naphthamido)-3-me...)
Affinity DataIC50: 688nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256573((S)-2-(3-(3-mesitylureido)-2-naphthamido)-5-methyl...)
Affinity DataIC50: 740nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256621((S)-2-(3-(3-mesitylureido)-2-naphthamido)-3-(neope...)
Affinity DataIC50: 949nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256443((S)-2-(3-(3-mesitylureido)-2-naphthamido)pentanoic...)
Affinity DataIC50: 1.02E+3nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256442((S)-2-(3-(3-mesitylureido)-2-naphthamido)-3,3-dime...)
Affinity DataIC50: 1.14E+3nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256622((S)-3-butoxy-2-(3-(3-mesitylureido)-2-naphthamido)...)
Affinity DataIC50: 1.14E+3nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256441((S)-2-(3-(3-mesitylureido)-2-naphthamido)-3-methyl...)
Affinity DataIC50: 1.17E+3nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256520((S)-2-(3-(3-mesitylureido)-2-naphthamido)-4-methyl...)
Affinity DataIC50: 1.43E+3nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256523(2-(3-(3-mesitylureido)-2-naphthamido)heptanoic aci...)
Affinity DataIC50: 1.53E+3nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256710((2S,3R)-3-(benzyloxy)-2-(3-(3-mesitylureido)-2-nap...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256444((2S,3S)-2-(3-(3-mesitylureido)-2-naphthamido)-3-me...)
Affinity DataIC50: 1.94E+3nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256522(6,6,6-trifluoro-2-(3-(3-mesitylureido)-2-naphthami...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of liver glycogen phosphorylase A in human HepG2 cells assessed as inhibition of forskolin-induced glucogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: